000 | 01818 a2200577 4500 | ||
---|---|---|---|
005 | 20250518033657.0 | ||
264 | 0 | _c20200413 | |
008 | 202004s 0 0 eng d | ||
022 | _a1744-8042 | ||
024 | 7 |
_a10.2217/pgs-2018-0169 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAaron, Michelle | |
245 | 0 | 0 |
_aIdentification of a single-nucleotide polymorphism within _h[electronic resource] |
260 |
_bPharmacogenomics _c04 2019 |
||
300 |
_a409-420 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAlleles |
650 | 0 | 4 |
_aAntigens, CD _xgenetics |
650 | 0 | 4 |
_aBone Density _xgenetics |
650 | 0 | 4 |
_aBone and Bones _xpathology |
650 | 0 | 4 |
_aCadherins _xgenetics |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGenetic Predisposition to Disease _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPolymorphism, Single Nucleotide _xgenetics |
650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xgenetics |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSurvivors |
650 | 0 | 4 |
_aExome Sequencing _xmethods |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aNadeau, Geneviève | |
700 | 1 | _aOuimet-Grennan, Erika | |
700 | 1 | _aDrouin, Simon | |
700 | 1 | _aBertout, Laurence | |
700 | 1 | _aBeaulieu, Patrick | |
700 | 1 | _aSt-Onge, Pascal | |
700 | 1 | _aShalmiev, Albert | |
700 | 1 | _aVeilleux, Louis-Nicolas | |
700 | 1 | _aRauch, Frank | |
700 | 1 | _aPetrykey, Kateryna | |
700 | 1 | _aLaverdière, Caroline | |
700 | 1 | _aSinnett, Daniel | |
700 | 1 | _aAlos, Nathalie | |
700 | 1 | _aKrajinovic, Maja | |
773 | 0 |
_tPharmacogenomics _gvol. 20 _gno. 6 _gp. 409-420 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2217/pgs-2018-0169 _zAvailable from publisher's website |
999 |
_c29587158 _d29587158 |